After more than 10 years in development, Regeneron secured a landmark approval for its monoclonal antibody garetosmab, now ...

Less than a year after the FDA turned down the resubmitted application for the company’s leukemia prospect Dasynoc, Xspray ...

China's investigator-initiated trials, once praised for their speediness, have been drawn into scrutiny for a lack of ...

Just eight months after it introduced its oral version of semaglutide for obesity, also known as the Wegovy pill, Novo ...

If at first you don’t succeed in gene therapy, then try, try again. | If at first you don’t succeed in gene therapy, then try ...

Eight months after more than doubling down on its construction of a $2 billion drug manufacturing facility in Holly Springs, ...

For patients living with Type 2 diabetes in the United Kingdom, a more convenient treatment option may be on the horizon ...

The pharmaceutical industry creates some of the most valuable products in human history: Medicines that can extend, save and better our lives. | The pharmaceutical industry creates some of the most ...

Aurinia Pharmaceuticals has struck a patent infringement settlement with Teva Pharmaceuticals, which should help stave off ...

SK’s deal with India’s MSN Laboratories will allow the Korean company to extend its market exclusivity beyond October of 2032 ...

Almost three years into his tenure as Lundbeck’s CEO, Charl van Zyl is confident the company can prove its mettle as a ...